Paper28640596
Drug-Target Kinetics in Drug Discovery.
Tonge PJ. ACS Chem Neurosci, 2018. Cited by 216 papers, by iCite.
Cite this record
ConductScience Library. Drug-Target Kinetics in Drug Discovery. Papers, record 28640596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28640596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Central Nervous System Neoplasms | Major topic |
| Drug Discovery | Major topic |
| Animals | |
| Humans | |
| Kinetics |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 GM102864 | NIGMS NIH HHS | United States | R01GM102864 | PubMed and NIH |
Source NIH RePORTER
References77
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27660682 | The Added Value of Assessing Ligand-Receptor Binding Kinetics in Drug Discovery. | ACS Med Chem Lett | 2016 | https://conductscience.org/library/papers/27660682 | PubMed |
| 2 | 24628038 | A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands. | Br J Pharmacol | 2014 | https://conductscience.org/library/papers/24628038 | PubMed |
| 3 | 15340390 | Biochemical mechanisms of drug action: what does it take for success? | Nat Rev Drug Discov | 2004 | https://conductscience.org/library/papers/15340390 | PubMed |
| 4 | 27096040 | Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR. | ACS Med Chem Lett | 2016 | https://conductscience.org/library/papers/27096040 | PubMed |
| 5 | 25630223 | Target engagement in lead generation. | Bioorg Med Chem Lett | 2015 | https://conductscience.org/library/papers/25630223 | PubMed |
| 6 | 17334377 | Structure-guided development of affinity probes for tyrosine kinases using chemical genetics. | Nat Chem Biol | 2007 | https://conductscience.org/library/papers/17334377 | PubMed |
| 7 | 16888652 | Drug-target residence time and its implications for lead optimization. | Nat Rev Drug Discov | 2006 | https://conductscience.org/library/papers/16888652 | PubMed |
| 8 | 28412474 | Kinetics for Drug Discovery: an industry-driven effort to target drug residence time. | Drug Discov Today | 2017 | https://conductscience.org/library/papers/28412474 | PubMed |
| 9 | 25399643 | Targeting protein kinases with selective and semipromiscuous covalent inhibitors. | Methods Enzymol | 2014 | https://conductscience.org/library/papers/25399643 | PubMed |
| 10 | 27414067 | Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. | J Med Chem | 2016 | https://conductscience.org/library/papers/27414067 | PubMed |
| 11 | 27547299 | Correlating Drug-Target Kinetics and In vivo Pharmacodynamics: Long Residence Time Inhibitors of the FabI Enoyl-ACP Reductase. | Chem Sci | 2016 | https://conductscience.org/library/papers/27547299 | PubMed |
| 12 | 26165720 | On the 'micro'-pharmacodynamic and pharmacokinetic mechanisms that contribute to long-lasting drug action. | Expert Opin Drug Discov | 2015 | https://conductscience.org/library/papers/26165720 | PubMed |
| 13 | 26006698 | NanoBRET--A Novel BRET Platform for the Analysis of Protein-Protein Interactions. | ACS Chem Biol | 2015 | https://conductscience.org/library/papers/26006698 | PubMed |
| 14 | 26484747 | Mechanistic models enable the rational use of in vitro drug-target binding kinetics for better drug effects in patients. | Expert Opin Drug Discov | 2016 | https://conductscience.org/library/papers/26484747 | PubMed |
| 15 | 23709115 | Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans. | J Pharmacol Exp Ther | 2013 | https://conductscience.org/library/papers/23709115 | PubMed |
| 16 | 22823083 | The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety. | Expert Opin Drug Discov | 2010 | https://conductscience.org/library/papers/22823083 | PubMed |
| 17 | 27094554 | Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists. | Sci Rep | 2016 | https://conductscience.org/library/papers/27094554 | PubMed |
| 18 | 27317944 | Pharmacological characterization of CRTh2 antagonist LAS191859: Long receptor residence time translates into long-lasting in vivo efficacy. | Pharmacol Res | 2016 | https://conductscience.org/library/papers/27317944 | PubMed |
| 19 | 27090615 | Conformational Adaption May Explain the Slow Dissociation Kinetics of Roniciclib (BAY 1000394), a Type I CDK Inhibitor with Kinetic Selectivity for CDK2 and CDK9. | ACS Chem Biol | 2016 | https://conductscience.org/library/papers/27090615 | PubMed |
| 20 | 26158339 | Type II Inhibitors Targeting CDK2. | ACS Chem Biol | 2015 | https://conductscience.org/library/papers/26158339 | PubMed |
Cited by132
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 216 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941873 | Peptides and Peptide Analogues Targeting Acetylcholinesterase-Associated Mechanisms in Alzheimer's Disease and Dementias: Evidence Gaps, Design Strategies, and Translational Perspectives. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941873 | PubMed |
| 42783177 | Retention-Based, Dissociation-Sensitive Pre-Screening of Aptamers Using a Centrifugal Microspin Filter. | Biosensors (Basel) | 2026 | https://conductscience.org/library/papers/42783177 | PubMed |
| 42771273 | Ligand-induced reshaping of the conformational free energy landscape drives dynamic restriction in Trypanosoma brucei alternative oxidase. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/42771273 | PubMed |
| 42310671 | Thermodynamic variations at the HPV E1-E2 interface correlate with clinical risk groups: an in-silico analysis. | Virol J | 2026 | https://conductscience.org/library/papers/42310671 | PubMed |
| 42250658 | The post antibiotic effect of streptogramins on gram-positive bacteria primarily arises from the type a component. | Microb Pathog | 2026 | https://conductscience.org/library/papers/42250658 | PubMed |
| 42239232 | Protein-ligand binding kinetics are primarily controlled by the protein, not the ligand. | bioRxiv | 2026 | https://conductscience.org/library/papers/42239232 | PubMed |
| 42154562 | Rebinding drives cellular retention of small-molecule drugs with abundant targets. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/42154562 | PubMed |
| 41992795 | Anticonvulsant Effects of Citronellal, Daidzin, and Phytol, Possibly Through GABAA Receptor and Voltage-Gated Sodium Channel Interaction Pathways: In Vivo and In Silico Studies. | Brain Behav | 2026 | https://conductscience.org/library/papers/41992795 | PubMed |
| 41824262 | Ocular Half-Life: What it Does and Does Not Mean for Intravitreal Anti-angiogenic Drug Durability. | Ophthalmol Ther | 2026 | https://conductscience.org/library/papers/41824262 | PubMed |
| 41698908 | A reversible allosteric inhibitor of GlyT2 for neuropathic pain without on-target side effects. | Nat Commun | 2026 | https://conductscience.org/library/papers/41698908 | PubMed |
| 41687504 | Altered residence time as a cause of drug resistance. | Curr Opin Struct Biol | 2026 | https://conductscience.org/library/papers/41687504 | PubMed |
| 41604481 | Efflux pumps control intracellular drug-target kinetics by limiting rebinding in bacteria. | Sci Adv | 2026 | https://conductscience.org/library/papers/41604481 | PubMed |
| 41409161 | An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/41409161 | PubMed |
| 41337752 | Selectivity of the Time-Dependent M. tuberculosis LeuRS Inhibitor Ganfeborole Is Driven by Target Vulnerability. | ACS Chem Biol | 2025 | https://conductscience.org/library/papers/41337752 | PubMed |
| 41332641 | A reversible allosteric inhibitor of GlyT2 alleviates neuropathic pain without on-target side effects. | bioRxiv | 2025 | https://conductscience.org/library/papers/41332641 | PubMed |
| 41216209 | Demonstrating the Absence of Correlation Between Molecular Docking and in vitro Cytotoxicity in Anti-Breast Cancer Research: Root Causes and Practical Resolutions. | Breast Cancer (Dove Med Press) | 2025 | https://conductscience.org/library/papers/41216209 | PubMed |
| 41144873 | Conformational Quenching in an Engineered Lipocalin Protein Achieves High Affinity Binding to the Toxin Colchicine. | Angew Chem Int Ed Engl | 2025 | https://conductscience.org/library/papers/41144873 | PubMed |
| 40884937 | How residence time works in allosteric drugs. | Curr Opin Struct Biol | 2025 | https://conductscience.org/library/papers/40884937 | PubMed |
| 40726426 | Modulating the Binding Kinetics of Bruton's Tyrosine Kinase Inhibitors through Transition-State Effects. | J Am Chem Soc | 2025 | https://conductscience.org/library/papers/40726426 | PubMed |
| 40634910 | Insights into the antiviral mechanisms of β-caryophyllene: inhibiting viral spread and its synergy with acyclovir. | BMC Complement Med Ther | 2025 | https://conductscience.org/library/papers/40634910 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28640596
GET https://conductscience.org/api/papers/v1/28640596/references?page=2